Preprint
Article

This version is not peer-reviewed.

In Silico Evaluation of Terpene Interactions with Inflammatory Enzymes: A Blind Docking Study Targeting Arachidonic Acid Metabolism

A peer-reviewed article of this preprint also exists.

Submitted:

06 June 2025

Posted:

09 June 2025

You are already at the latest version

Abstract
Terpenes are a structurally diverse group of plant-derived compounds increasingly recognized for their potential anti-inflammatory properties. In this study, blind molecular docking was performed to assess the interactions of six naturally occurring terpenes—α-pinene, β-pinene, menthol, camphor, limonene, and linalool—with four enzymes central to arachidonic acid (AA) metabolism: cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and phospholipase A2 (PLA2). Arachidonic acid served as a reference ligand. Docking simulations using AutoDock 4.2 and the Lamarckian Genetic Algorithm enabled the evaluation of binding affinities, inhibition constants (Ki), and contact residues. Menthol and limonene showed strong binding affinity for 5-LOX, while α-pinene, menthol, and limonene exhibited higher affinity for PLA2 compared to AA. Residue-level interaction analysis revealed that β-pinene matched catalytic residues in PLA2, and all terpenes except camphor formed interactions with catalytically relevant residues in COX-2. All six compounds interacted with the active site of COX-1, whereas only linalool exhibited such interactions in 5-LOX. These findings suggest that specific terpenes may modulate inflammatory processes through interference with key enzymatic targets. However, further studies incorporating flexible-body docking and molecular dynamics are recommended to better elucidate the dynamic nature of these interactions and their potential pharmacological relevance.
Keywords: 
;  ;  ;  ;  

1. Introduction

Inflammation is a complex biological response triggered by harmful stimuli such as injuries, infections, pathogens, and other foreign substances. The organism responds to these stimuli through a coordinated mechanism that involves the elimination of pathogenic factors and the activation of protective systems for self-repair and immune defense [1].
At the tissue level, inflammation manifests through redness, swelling, heat, pain, and loss of tissue function—hallmarks resulting from local immune, vascular, and cellular inflammatory responses to infection or injury [2]. Microcirculatory events occurring during the inflammatory process include increased vascular permeability, recruitment and accumulation of leukocytes, and the release of inflammatory mediators [3,4].
In certain diseases, the immune system triggers an inflammatory response in the absence of foreign substances or infection. These heterogeneous conditions are characterized by the excessive production of pro-inflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) [5].
The inflammatory response involves the coordinated activation of signaling pathways that regulate the levels of inflammatory mediators in both tissue-resident and immune cells. Inflammation is a common pathogenic mechanism in many chronic diseases, including cardiovascular and gastrointestinal disorders, diabetes, arthritis, and malignancies [6]. Although the specific features of the inflammatory response depend on the nature and location of the initial stimulus, these processes share a common mechanism that can be summarized as follows: (1) cell surface receptors recognize harmful stimuli; (2) inflammatory pathways are activated; (3) inflammatory markers are released; and (4) immune cells are recruited to the affected site [7].
Synthetic anti-inflammatory drugs are widely used to suppress or inhibit pro-inflammatory mediators. However, the use of such medications is often associated with adverse side effects, such as gastric and duodenal ulcerations, which can reduce patient adherence to prescribed therapies. For this reason, in recent years, natural products have received increasing attention for their potential anti-inflammatory effects [8].
Terpenes constitute a large and structurally diverse group of natural compounds synthesized by plants [9]. This family comprises approximately 55,000 compounds with varying chemical structures and, consequently, distinct biological functions. Evidence from the scientific literature indicates that terpenoids can modulate the inflammatory process by inhibiting various molecular pathways, suggesting their potential as anti-inflammatory agents [10].
The aim of the present study is to evaluate the in silico anti-inflammatory potential of six terpenes—α-pinene, β-pinene, menthol, camphor, limonene, and linalool—by performing molecular docking analysis of their interactions with key enzymes involved in the inflammatory cascade: cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), phospholipase A2 (PLA2), and 5-lipoxygenase (5-LOX).

2. Materials and Methods

The three-dimensional structures of the target enzymes were retrieved from the Protein Data Bank (PDB) to serve as the basis for molecular docking and structural analysis. Specifically, COX-1 was obtained under PDB ID 6Y3C, and COX-2 under 3HS5 [11,12]. The structure of 5-LOX was sourced using PDB ID 3O8Y, while PLA2 was retrieved under 1KVO [13,14].
Prior to performing the docking studies, all molecular structures were optimized and preprocessed using Open Babel 2.4.0 [15], Avogadro [16], ChimeraX [17], and AutoDock Tools [18]. This preprocessing ensured structural uniformity and consistency across all compounds. All protein structures were prepared by removing non-essential molecules, such as water and co-crystallized ligands, prior to docking simulations. Hydrogen atoms were added, and proper protonation states were assigned based on physiological pH to ensure structural integrity and compatibility with subsequent molecular modeling protocols.
Ligands were subjected to blind docking using 100 independent runs of the genetic algorithm (GA) search. Blind docking is a molecular docking approach in which the entire surface of the target protein is scanned to identify potential binding sites, as opposed to standard docking, which restricts the search to a predefined active site or binding pocket. This method is particularly valuable when the binding site is unknown or when exploring potential allosteric interactions. In this study, blind docking was performed using a grid box encompassing the entire protein surface, ensuring comprehensive spatial coverage for unbiased ligand binding prediction [19,20,21].
The Lamarckian Genetic Algorithm (LGA) was employed, with the following parameters: a maximum of 25,000,000 energy evaluations, 27,000 maximum generations, a gene mutation rate of 0.02, and a crossover rate of 0.8. Cluster analysis of the docking results was performed using a root-mean-square deviation (RMSD) tolerance of 2 Å [22].
The conformation with the lowest binding energy from each docking simulation was selected as the best docking result.

3. Results

3.1. COX-1 interactions

The interaction parameters of the selected terpenes with COX-1, compared to arachidonic acid (AA), are summarized in Table 1.
One of the fundamental parameters for evaluating ligand–enzyme interactions is the binding energy, expressed in kcal/mol. Lower binding energy values correlate with the formation of more stable ligand–enzyme complexes, which, in turn, indicate higher binding affinity.
In the present study, AA exhibits the lowest binding energy (−7.53 kcal/mol), reflecting its strong interaction with COX-1. Among the terpenes analyzed, menthol has the lowest binding energy (−6.56 kcal/mol), followed by camphor (−6.32 kcal/mol) and β-pinene (−6.31 kcal/mol), suggesting that these compounds possess relatively high affinity for COX-1.
The inhibition constant (Ki) represents another indicator of the potential inhibitory activity of the studied molecules, with lower Ki values corresponding to greater inhibitory potential. The lowest Ki value is observed for AA (3.02 µM), consistent with its role as the natural substrate of COX-1. Among the terpenes, menthol (15.50 µM) and camphor (23.37 µM) exhibit the lowest Ki values, suggesting that these compounds may exert inhibitory activity toward the enzyme.
The root mean square deviation (RMSD) values, relative to the reference structure, provide insights into the extent of conformational changes undergone by the ligands upon binding. High RMSD values (>50 Å) are recorded for all analyzed molecules, indicating significant spatial reorientation. The highest RMSD values are observed for camphor (67.64 Å) and β-pinene (67.775 Å), suggesting that these molecules undergo substantial conformational changes upon binding to COX-1.
The total internal energy and torsional free energy provide additional insight into the molecular stability of the ligands. The highest torsional energy values are recorded for linalool (+1.49 kcal/mol) and AA (+4.47 kcal/mol), suggesting increased flexibility and a greater tendency for conformational changes. In contrast, menthol exhibits the lowest torsional energy (+0.60 kcal/mol), indicating a relatively stable conformation upon binding to COX-1.
Unbound energy is a parameter reflecting the energetic state of the molecule in its free form. The lowest unbound energy is observed for AA (−1.61 kcal/mol), consistent with its high binding affinity.
In summary, AA exhibits the highest affinity for COX-1, consistent with its role as the enzyme’s natural substrate. Among the terpenes investigated, menthol and camphor demonstrate the most favorable parameters, identifying them as potential COX-1 inhibitors. In contrast, linalool and α-pinene show relatively weaker interactions, likely due to their higher torsional energy and conformational flexibility.
A 3D visualization of the interactions between the terpenes, AA, and the COX-1 enzyme is presented in Figure 1. Ligands are shown in ball-and-stick representation (light brown), and the enzyme is displayed as a cartoon structure (cyan). Hydrogen bonds and relevant interactions are indicated with dashed lines where applicable. The positioning of each ligand relative to key catalytic residues illustrates potential binding modes and differences in spatial orientation.

3.2. COX-2 interactions

The interaction parameters of the selected terpenes with COX-2, compared to AA, are summarized in Table 2.
AA exhibits the lowest binding energy (−7.07 kcal/mol), indicating strong interaction with COX-2. Among the terpenes analyzed, camphor has the lowest binding energy (−6.48 kcal/mol), followed by menthol (−6.42 kcal/mol).
The lowest Ki value is also observed for AA (6.55 µM), which is expected given its natural role in COX-2 enzymatic reactions. Among the terpenes, camphor (17.84 µM) and menthol (19.80 µM) exhibit the lowest Ki values, identifying them as potential COX-2 inhibitors.
The observed high RMSD values (>50 Å) for all analyzed molecules indicate significant spatial reorientation upon binding. The highest RMSD values are recorded for β-pinene (67.77 Å) and menthol (67.75 Å), suggesting substantial conformational changes during interaction with the enzyme.
Among all terpenes studied, the highest torsional energy is observed for linalool (+1.49 kcal/mol) and AA (+4.47 kcal/mol), indicating greater molecular flexibility. In contrast, α-pinene and β-pinene exhibit zero torsional energy (+0.00 kcal/mol), suggesting conformational stability upon binding.
The lowest unbound energy is recorded for AA (−1.18 kcal/mol), consistent with its high binding affinity.
The results indicate that, among all compounds studied, AA exhibits the highest affinity for COX-2, consistent with its role as the enzyme’s natural substrate. Among the terpenes, camphor and menthol demonstrate the most favorable parameters, identifying them as potential COX-2 inhibitors. In contrast, linalool and α-pinene show comparatively weaker interactions, likely due to their higher torsional energy and conformational flexibility.
A 3D visualization of the interactions between the terpenes, AA, and the COX-2 enzyme is presented in Figure 2. Ligands are shown in ball-and-stick representation (light brown), and the enzyme is displayed as a cartoon structure (cyan). Hydrogen bonds and relevant interactions are indicated with dashed lines where applicable. The positioning of each ligand relative to key catalytic residues illustrates potential binding modes and differences in spatial orientation.
3.3. 5-LOX interactions
The interaction parameters of the selected terpenes with 5-LOX, compared to AA, are summarized in Table 3.
Limonene (−5.57 kcal/mol), menthol (−5.45 kcal/mol), and AA (−5.45 kcal/mol) exhibit the lowest binding energies, indicating stable interactions with 5-LOX. The remaining terpenes also demonstrate relatively favorable binding energies, with camphor displaying the highest value (−5.17 kcal/mol), which may suggest weaker interaction with the enzyme.
Limonene (82.28 µM), AA (101.13 µM), and menthol (102.00 µM) exhibit the lowest Ki values among the tested compounds, identifying them as the most promising potential 5-LOX inhibitors. In contrast, linalool shows a substantially higher Ki value (564.63 µM), indicating a significantly lower affinity for 5-LOX.
High RMSD values (>50 Å) are observed for camphor (77.022 Å) and limonene (64.854 Å), suggesting notable structural changes upon binding. Conversely, α-pinene (19.328 Å) and β-pinene (18.577 Å) demonstrate the lowest RMSD values, indicating minimal conformational changes during interaction with the enzyme.
Linalool (+1.49 kcal/mol) and AA (+4.47 kcal/mol) exhibit the highest torsional energies, suggesting greater conformational flexibility. In contrast, menthol (+0.60 kcal/mol) and α-pinene (+0.00 kcal/mol) show the lowest torsional energy values, indicating stable conformations upon binding to 5-LOX.
The lowest unbound energy is recorded for AA (−1.08 kcal/mol), supporting its high affinity for the enzyme.
The analysis reveals that limonene, menthol, and AA display the lowest binding energies, suggesting stable interactions with 5-LOX. Menthol and AA also demonstrate the lowest Ki values. In contrast, linalool exhibits the weakest affinity, suggesting lower inhibitory potential.
A 3D visualization of the interactions between the terpenes, AA, and the 5-LOX enzyme is presented in Figure 3. Ligands are shown in ball-and-stick representation (light brown), and the enzyme is displayed as a cartoon structure (cyan). Hydrogen bonds and relevant interactions are indicated with dashed lines where applicable. The positioning of each ligand relative to key catalytic residues illustrates potential binding modes and differences in spatial orientation.

3.4. PLA2 interactions

The interaction parameters of the selected terpenes with PLA2, compared to AA, are summarized in Table 4.
Limonene (−6.58 kcal/mol) exhibits the lowest binding energy, followed by menthol (−6.57 kcal/mol) and AA (−6.23 kcal/mol), indicating stable interactions with PLA2. The remaining terpenes also show good affinity, with β-pinene presenting the highest binding energy (−5.28 kcal/mol), which may indicate weaker interaction with the enzyme.
Among the terpenes, limonene (14.99 µM) and menthol (15.22 µM) exhibit the lowest Ki values, identifying them as the most promising potential inhibitors of PLA2. In contrast, β-pinene shows the highest Ki value (134.07 µM), indicating a weaker affinity for the enzyme.
High RMSD values are recorded for camphor (96.944 Å), linalool (96.905 Å), and menthol (98.205 Å), suggesting significant structural changes upon binding to PLA2. Notably, α-pinene (110.729 Å) and β-pinene (100.997 Å) exhibit the highest RMSD values, indicating pronounced flexibility during interaction.
The highest torsional energies are observed for α-pinene (+1.49 kcal/mol) and AA (+4.47 kcal/mol), suggesting greater conformational flexibility. In contrast, menthol (+0.60 kcal/mol) and limonene (+0.26 kcal/mol) display lower torsional energies, which may indicate more stable conformations when bound to PLA2.
AA exhibits the lowest unbound energy (−1.91 kcal/mol), consistent with its high affinity for PLA2. It is followed by α-pinene (−0.26 kcal/mol) and menthol (−0.17 kcal/mol).
The analysis reveals that limonene and menthol have the lowest binding energies, suggesting stable interactions with PLA2. These two compounds also demonstrate the lowest Ki values, identifying them as potential inhibitors of the enzyme. In contrast, β-pinene shows the weakest affinity, likely due to its high Ki value.
A 3D visualization of the interactions between the terpenes, AA, and the PLA2 enzyme is presented in Figure 4. Ligands are shown in ball-and-stick format, surrounded by a space-filling surface representation of the protein to illustrate spatial accommodation and surface contact. The visualization highlights the degree of penetration and positioning of each ligand within the catalytic pocket of PLA₂.

3.5. Blind docking results

Table 5 presents the amino acid sequences of the active sites of the enzymes investigated in this study.
Table 6 presents the results of the blind docking analysis of the interactions between the selected terpenes and the enzymes involved in arachidonic acid metabolism. For comparative evaluation, arachidonic acid was included as a reference ligand. The table lists the amino acid residues involved in ligand–enzyme interactions as predicted by molecular docking, along with a comparison to known catalytic residues (“Match”). “Match” refers to overlap between contact residues and literature-defined catalytic residues for each enzyme, suggesting potential for functional inhibition.
For each ligand–enzyme complex, the following parameters were determined:
  • Active site sequence: A list of amino acid residues forming the catalytic site of the corresponding enzyme.
  • Binding residues: Specific residues through which the terpene establishes contact with the enzyme during docking.
  • Matches: Residues that appear most frequently across simulations, indicating potentially stable interactions and playing a key role in stabilizing the complex.
The data indicate that the terpenes interact selectively with the enzymes involved in arachidonic acid metabolism, establishing specific contacts within their active sites.
COX-1 is a constitutively expressed enzyme involved in the synthesis of prostaglandins essential for maintaining gastrointestinal and renal homeostasis. The analysis reveals that key contact residues within the active site include LEU117, ARG120, PHE205, PHE209, TYR348, PHE381, TYR385, and HIS388. Limonene forms a stable contact with PHE381, a residue within the active site. Camphor, linalool, menthol, α-pinene, and β-pinene exhibit strong interactions with HIS388 and TYR385, which may contribute to their affinity for the enzyme. Additionally, α-pinene and β-pinene interact with TRP387, which could play a stabilizing role in ligand binding.
COX-2 is inducible under inflammatory conditions and is a preferred target for selective inhibitors. The primary amino acid residues involved in terpene interactions include TYR385, HIS388, TRP387, PHE381, and VAL349. Limonene again shows affinity for PHE381. In the case of camphor, no overlap can be observed between the ligand–enzyme interaction residues and the active site residues of COX-2. Linalool, menthol, α-pinene, and β-pinene demonstrate stable binding with HIS388 and TYR385, consistent with the patterns observed for COX-1. α-Pinene and β-pinene also exhibit specific affinity for TRP387, which may influence their selectivity toward COX-2.
5-LOX catalyzes the first step in leukotriene biosynthesis, which plays a critical role in chronic inflammatory diseases. The key amino acid residues involved in ligand binding include HIS367, HIS372, HIS550, TYR181, and TRP599. Among the tested compounds, only linalool shows stable contacts with LEU414, TRP599, ALA603 and TYR181, which overlap with its interaction profile in COX-2. For the remaining terpenes, no overlap is observed between the ligand–enzyme interaction residues and the amino acid sequence of the 5-LOX active site.
PLA₂ is responsible for releasing AA from membrane phospholipids, representing the initial step in the inflammatory cascade. The main contact residues in the enzyme’s active site include HIS47, CYS44, TYR51, and PHE5. Among the terpenes, only β-pinene exhibits matching interactions, forming stable contacts with PHE5, CYS44, and HIS47, which are part of the active site of the phospholipase enzyme.

4. Discussion

In the present study, the anti-inflammatory properties of six terpenes are evaluated in silico through molecular docking against four enzymes involved in the inflammatory cascade. Arachidonic acid is used as a reference substrate, as it is the natural ligand for these enzymes and plays a central role in the synthesis of pro-inflammatory mediators.
The results show that for both COX-1 and COX-2, AA exhibits the lowest binding energy and Ki values, confirming its optimal positioning within the catalytic site. Among the terpenes studied, menthol and camphor show a tendency to bind near critical catalytic residues, although they do not achieve the full interaction profile characteristic of AA. This is reflected in their higher Ki values, suggesting that despite thermodynamically favorable docking scores, their overall affinity for COX-1 and COX-2 remains lower than that of the natural substrate.
In contrast, a different pattern is observed in the analysis of 5-LOX and PLA₂. Limonene and menthol can be positioned in close proximity to key catalytic residues essential for enzymatic function, which is supported by their favorable binding energy and Ki values. This suggests that they may exert a competitive effect by hindering the normal binding and function of AA within the active sites. Such positioning, combined with their relatively low torsional free energy—indicating more stable conformations upon binding—highlights their potential as inhibitors of 5-LOX and PLA₂.
Although cluster analysis is performed using a 2 Å RMSD threshold to group geometrically similar poses, certain high-RMSD docking results are retained for further evaluation due to their interactions with catalytically important residues reported in the literature. This strategy ensures that biologically relevant binding modes were not disregarded solely on the basis of geometric deviation. A comprehensive analysis of conformational parameters, including RMSD values and torsional free energy, indicate that many ligands undergo notable structural rearrangements upon enzyme binding. In particular, linalool and arachidonic acid exhibit higher torsional energies, suggesting a greater degree of conformational flexibility and the potential to adopt multiple orientations within the active site. Conversely, the lower torsional energies which are observed for limonene and menthol point to more rigid and stable binding poses, a feature that may contribute to more effective inhibition of enzymatic activity.
Despite these encouraging in silico results, it is important to acknowledge the limitations of the molecular docking approach. The rigid protein structures used during docking do not fully reflect the dynamic flexibility of enzymes, and conformational changes associated with the induced fit mechanism remain unresolved. Additionally, factors such as solvent effects, entropic contributions, and the specific ionization states of catalytic residues cannot be fully captured by docking algorithms. These limitations warrant caution when extrapolating in silico findings to actual biological activity.
The comparison of ligand–residue contacts with literature-defined catalytic residues provides additional insight into whether the ligand is positioned in close proximity to the enzyme’s functional center. In cases where a high degree of overlap is observed, lower binding energy and Ki values are typically recorded, supporting the conclusion that these interactions are not incidental, but reflect a real mechanism of enzymatic inhibition.
The observed interactions between the docked terpenoid compounds and key active site residues—previously identified as critical for arachidonic acid binding—suggest a potential for these molecules to interfere with the enzyme’s ability to process arachidonic acid. This supports the hypothesis that such terpenes may modulate the arachidonic acid metabolic pathway, potentially contributing to anti-inflammatory effects.
For COX-1 and COX-2, AA - despite its thermodynamically favorable binding profile—did not always align fully with key catalytic residues, which may be attributed to conformational characteristics of the selected protein structure. In contrast, limonene and menthol demonstrate more precise positioning within critical regions of 5-LOX and PLA₂, supporting their candidacy as potential inhibitors in these systems.
In addition to analyzing binding energies and Ki values, the structure–activity relationship between molecular parameters and the ability to establish contacts with amino acid residues proves to be particularly important in evaluating terpene potential. Molecules that fail to reach the active site, or that interact only peripherally, are likely to exhibit weaker inhibitory effects—even if their thermodynamic parameters appear favorable.

5. Conclusions

The present study demonstrates that, although arachidonic acid remains the most potent substrate for COX-1 and COX-2, certain terpenes—particularly limonene and menthol—exhibit comparable or even higher affinity than AA toward 5-LOX and PLA₂. This positions them as promising candidates for further investigation in the context of novel anti-inflammatory drug discovery. Additional experimental studies are required to validate and expand upon these findings, ultimately contributing to the development of more effective and selective anti-inflammatory therapeutics.

Author Contributions

Conceptualization, I.I and D.C; methodology, I.I., D.C., N.A., G.Y., T.D., N.A. and S.G.; software, I.I. and K.M.; validation, I.I., and D.C; formal analysis, I.I. and D.C.; investigation, I.I. and D.C; resources, I.I., D.C., K.M., N.A., G.Y. T.D. and S.G.; data curation, I.I. and D.C.; writing—original draft preparation, I.I. and D.C.; writing—review and editing, G.Y. and S.G.; visualization, I.I. and K.M.; supervision G.Y. and S.G.; project administration, D.C.; funding acquisition, G.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. This research was supported by the Medical University of Varna „Prof. Dr. Paraskev Stoyanov”.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wound Repair: Results of a Pre-clinical Study to Evaluate Electropsun Collagen-Elastin-PCL Scaffolds as Dermal Substitutes. Burns 45 2019, 1639–1648. [CrossRef]
  2. Takeuchi, O.; Akira, S. Pattern Recognition Receptors and Inflammation. Cell. 2010, 140, 805–820. [Google Scholar] [CrossRef] [PubMed]
  3. Ferrero-Miliani, L.; Nielsen, O.; Andersen, P.; Girardin, S. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin Exp Immunol. 2007, 147, 227–235. [Google Scholar] [CrossRef] [PubMed]
  4. Chertov, O.; Yang, D.; Howard, O.; Oppenheim, J.J. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev. 2000, 177, 68–78. [Google Scholar] [CrossRef] [PubMed]
  5. Gu, J.H.; Ge, J.B.; Li, M.; Wu, F.; Zhang, W.; Qin, Z.H. Inhibition of NF-Κb Activation Is Associated with Anti-inflammatory and Anti-Apoptotic Effects of Ginkgolide B in a Mouse Model of Cerebral Ischemia/Reperfusion Injury. Eur. J. Pharm. Sci. 2012, 47, 652–660. [Google Scholar] [CrossRef] [PubMed]
  6. Lawrence, T. The Nuclear Factor NF-κB Pathway in Inflammation. CSH Perspect Biol. 2009.
  7. Libby, P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007, 65, 140–146. [Google Scholar] [CrossRef]
  8. Del Prado-Audelo, ML.; Cortés, H.; Caballero-Florán, I.H.; González-Torres, M.; Escutia-Guadarrama, L.; Bernal-Chávez, SA.; Giraldo-Gomez, D.M.; Magaña, J.J.; Leyva-Gómez, G. Therapeutic Applications of Terpenes on Inflammatory Diseases. Front Pharmacol. 2021, 12, 704197. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  9. Prakash, V. Terpenoids as Source of Anti-Inflammatory Compounds. Asian J. Pharm. Clin. Res. 2017, 10, 68–76. [Google Scholar] [CrossRef]
  10. Serrano Vega, R. J.; Campos Xolalpa, N.; Castro Alonso, J. A.; González Pérez, C.; Pérez Ramos, J.; Pérez Gutiérrez, S. “Terpenes from from Natural Natural Products Products with with Potential Potential Anti- Activity Inflammatory Activity”. in Terpenes from Natural Products with Potential Anti-Inflammatory Activity. Perveen, S., Al-Taweel, A., Eds.; London: Intech Open, 2018; pp 59–85. [CrossRef]
  11. Miciaccia, M.; Belviso, B.D.; Iaselli, M.; Cingolani, G.; Ferorelli, S.; Cappellari, M.;, Loguercio Polosa,.; P.; Perrone, M.G.; Caliandro, R.; Scilimati, A. Three-dimensional structure of human cyclooxygenase (hCOX)-1. Sci Rep. 2021, 11(1), 4312. [CrossRef] [PubMed] [PubMed Central]
  12. Vecchio, A.J.; Simmons, D.M.; Malkowski, M.G. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem. 2010, 285(29), 22152–63. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  13. Gilbert, N.C.; Bartlett, S.G.; Waight, M, T.; Neau, D.B.; Boeglin, W.E.; Brash, A.R.; Newcomer, M.E. The structure of human 5-lipoxygenase. Science 2011, 14, 331(6014), 217-9. PMID: 21233389; PMCID: PMC3245680. [CrossRef]
  14. Cha, S.S.; Lee, D.; Adams, J.; Kurdyla, J.T.; Jones, C.S.; Marshall, L.A.; Bolognese, B.; Abdel-Meguid, S.S.; Oh, B.H. ; High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX). J Med Chem. 1996, 39(20), 3878–81. [Google Scholar] [CrossRef] [PubMed]
  15. O’Boyle, N.M.; Banck, M.; James, C.A.; Morley, C.; Vandermeersch, T.; Hutchison, G.R. Open Babel: An open chemical toolbox. J Cheminform. 2011, 3, 1–14. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  16. Hanwell, M.D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; Hutchison, G. R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012, 4, 1–17. [Google Scholar] [CrossRef] [PubMed]
  17. Read, R.J.; Pettersen, E.F.; McCoy, A.J.; Croll, TI.; Terwilliger, T.C.; Poon, B.K.; Meng, E.C.; Liebschner, D.; Adams, P.D. Likelihood-based interactive local docking into cryo-EM maps in ChimeraX. Acta Crystallogr D Struct Biol. 2024, 80(8), 588–598. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  18. Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell., D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009, 30, 2785–2791. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  19. Torres, P.H.M.; Sodero, A.C.R.; Jofily, P.; Silva-Jr, F.P. Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019, 20(18), 4574. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  20. Yuriev, E.; Ramsland, P.A. Latest developments in molecular docking: 2010-2011 in review. J Mol Recognit. 2013, 26(5), 215–39. [Google Scholar] [CrossRef] [PubMed]
  21. Sulimov, V.B.; Kutov, D.C.; Sulimov, A.V. Advances in Docking. Curr Med Chem. 2019, 26(42), 7555–7580. [Google Scholar] [CrossRef] [PubMed]
  22. Fuhrmann, J.; Rurainski, A.; Lenhof, H.P.; Neumann, D. A new Lamarckian genetic algorithm for flexible ligand-receptor docking. J Comput Chem. 2010, 31(9), 1911–8. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the COX-1 enzyme.
Figure 1. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the COX-1 enzyme.
Preprints 162639 g001
Figure 2. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the COX-2 enzyme.
Figure 2. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the COX-2 enzyme.
Preprints 162639 g002
Figure 3. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the 5-LOX enzyme.
Figure 3. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the 5-LOX enzyme.
Preprints 162639 g003
Figure 4. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the PLA2 enzyme.
Figure 4. Comparative 3D visualization of the binding interactions between selected terpenes, arachidonic acid (AA), and the PLA2 enzyme.
Preprints 162639 g004
Table 1. In silico docking results for interactions between selected terpenes and COX-1: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
Table 1. In silico docking results for interactions between selected terpenes and COX-1: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
COX-1 Limonene Camphor Linalool Menthol α-pinene β-pinene AA
Conformations 2 13 33 20 54 60 9
RMSD from reference structure 59.121 A 67.643 A 66.924 A 67.481 A 66.995 A 67.775 A 57.255 A
Binding energy -5.99 kcal/mol -6.32 kcal/mol -5.82 kcal/mol -6.56 kcal/mol -6.20 kcal/mol -6.31 kcal/mol -7.53 kcal/mol
Inhibition Constant, Ki 40.60 µM 23.37 µM 54.64 µM 15.50 µM 28.74 µM 23.61 µM 3.02 µM
Total Internal energy -0.13 kcal/mol +0.00 kcal/mol -0.33 kcal/mol -0.17 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -1.61 kcal/mol
Torsional Free Energy +0.30 kcal/mol +0.00 kcal/mol +1.49 kcal/mol +0.60 kcal/mol +0.00 kcal/mol +0.00 kcal/mol +4.47 kcal/mol
Unbound Energy -0.13 kcal/mol +0.00 kcal/mol -0.33 kcal/mol -0.17 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -1.61 kcal/mol
Table 2. In silico docking results for interactions between selected terpenes and COX-2: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
Table 2. In silico docking results for interactions between selected terpenes and COX-2: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
COX-2 Limonene Camphor Linalol Menthol α-pinene β-pinene AA
Conformations 3 13 19 26 36 46 7
RMSD from reference structure 59.204 A 67.674 A 66.971 A 67.752 A 67.087 A 67.770 A 58.016 A
Binding energy -5.96 kcal/mol -6.48 kcal/mol -5.79 kcal/mol -6.42 kcal/mol -6.18 kcal/mol -6.31 kcal/mol -7.07 kcal/mol
Inhibition Constant, Ki 43.00 µM 17.84 µM 56.61 µM 19.80 µM 29.44 µM 23.61 µM 6.55 µM
Total Internal energy -0.13 kcal/mol +0.00 kcal/mol -0.37 kcal/mol -0.16 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -1.18 kcal/mol
Torsional Free Energy +0.30 kcal/mol +0.00 kcal/mol +1.49 kcal/mol +0.60 kcal/mol +0.00 kcal/mol +0.00 kcal/mol +4.47 kcal/mol
Unbound Energy -0.13 kcal/mol +0.00 kcal/mol -0.37 kcal/mol -0.16 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -1.18 kcal/mol
Table 3. In silico docking results for interactions between selected terpenes and 5-LOX: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
Table 3. In silico docking results for interactions between selected terpenes and 5-LOX: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
5-LOX Limonene Camphor Linalool Menthol α-pinene β-pinene AA
Conformations 15 13 1 14 32 26 1
RMSD from reference structure 64.854 A 77.022 A 23.527 A 64.372 A 19.328 A 18.577 A 28.948 A
Binding energy -5.57 kcal/mol -5.17 kcal/mol -4.43 kcal/mol -5.45 kcal/mol -4.89 kcal/mol -4.85 kcal/mol -5.45 kcal/mol
Inhibition Constant, Ki 82.28 µM 161.15 µM 564.63 µM 102.00 µM 261.53 µM 280.35 µM 101.13 µM
Total Internal energy -0.13 kcal/mol +0.00 kcal/mol -0.39 kcal/mol -0.16 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -1.08 kcal/mol
Torsional Free Energy +0.30 kcal/mol +0.00 kcal/mol +1.49 kcal/mol +0.60 kcal/mol +0.00 kcal/mol +0.00 kcal/mol +4.47 kcal/mol
Unbound Energy -0.13 kcal/mol +0.00 kcal/mol -0.39 kcal/mol -0.16 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -1.08 kcal/mol
Table 4. In silico docking results for interactions between selected terpenes and PLA2: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
Table 4. In silico docking results for interactions between selected terpenes and PLA2: binding energy, conformational parameters, inhibition constants (Ki), and energy descriptors compared to arachidonic acid (AA).
PLA2 Limonene Camphor Linalool Menthol α-pinene β-pinene AA
Conformations 19 6 11 6 8 25 2
RMSD from reference structure 89.108 A 96.944 A 96.905 A 98.205 A 110.729 A 100.997 A 98.253 A
Binding energy -6.58 kcal/mol -5.94 kcal/mol -6.00 kcal/mol -6.57 kcal/mol -6.49 kcal/mol -5.28 kcal/mol -6.23 kcal/mol
Inhibition Constant, Ki 14.99 µM 44.43 µM 39.77 µM 15.22 µM 17.50 µM 134.07 µM 27.27 µM
Total Internal energy -0.13 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -0.17 kcal/mol -0.26 kcal/mol +0.00 kcal/mol -1.91 kcal/mol
Torsional Free Energy +0.30 kcal/mol +0.00 kcal/mol +0.00 kcal/mol +0.60 kcal/mol +1.49 kcal/mol +0.00 kcal/mol +4.47 kcal/mol
Unbound Energy -0.13 kcal/mol +0.00 kcal/mol +0.00 kcal/mol -0.17 kcal/mol -0.26 kcal/mol +0.00 kcal/mol -1.91 kcal/mol
Table 5. Active site amino acid residues in COX-1, COX-2, 5-LOX and PLA2 enzymes.
Table 5. Active site amino acid residues in COX-1, COX-2, 5-LOX and PLA2 enzymes.
Enzyme Active Site Bibliography
COX-1 LEU117, ARG120, PHE205, PHE209, VAL344, ILE345, TYR348, VAL349, LEU352, SER353, TYR355, PHE381, TYR385, TRP387, ILE523, HIS207, HIS388, GLN203 [11]
COX-2 TYR385, SER530, LEU531, VAL116, ALA527, VAL349, TYR355, LEU352, VAL523, PHE518, PHE205, PHE209, TYR348, VAL349, LEU352, PHE381, TYR385, TRP387, VAL523, ALA527, LEU534 [12]
5-LOX HIS367, HIS372, HIS550, PHE177, TYR181, LEU368, LEU414, ILE406, ALA603, ALA606, TRP599, ASN407, HIS432 [13]
PLA2 PHE5, HIS6, ILE9, ALA18, TYR21, GLY22, GLY29, GLY32, CYS44, HIS47, TYR51 [14]
Table 6. Interaction profile of selected terpenes and arachidonic acid (AA) with the active sites of COX-1, COX-2, 5-LOX, and PLA₂ enzymes.
Table 6. Interaction profile of selected terpenes and arachidonic acid (AA) with the active sites of COX-1, COX-2, 5-LOX, and PLA₂ enzymes.
Terpene Enzyme Interaction Match
Limonene COX-1 PRO128, ARG376, PRO125, ALA378, ILE124, ILE377, PHE529, PHE381, LYS532 PHE381
COX-2 PRO125, PRO128, ARG376, ILE124, ILE377, PHE529, LYS532, ALA378, PHE381 PHE381
5-LOX LEU448, TYR470, ILE454, PHE450, VAL243, ALA453 No match.
PLA2 PHE63, LYS62, PHE63 No match.
Camphor COX-1 ALA202, LEU390, MET391, THR206, HIS388 HIS388
COX-2 ALA202, HIS388, THR206, MET391, LEU390 No match.
5-LOX HIS130, VAL110, VAL109, ARG101, LYS133 No match.
PLA2 LYS62, LEU64, PHE63, PHE63 No match.
Linalool COX-1 HIS388, HIS386, LEU390, TYR385, ALA202, PHE21 HIS388, TYR385
COX-2 LEU390, MET391, ALA202, HIS388, HIS207, PHE210, HIS386, THR206, TYR385 TYR385
5-LOX PHE359, PHE412, LEU414, TRP599, VAL604, HIS600, ALA603, TYR181, LEU420, ALA424 LEU414, TRP599, ALA603, TYR181
PLA2 LYS62, LEU64, LEU64, PHE63 No match.
Menthol COX-1 HIS388, TYR385, ALA202, MET391, LEU390, ALA199 HIS388, TYR385
COX-2 HIS388, TYR385, ALA202, MET391, LEU390, ALA199 TYR385
5-LOX PHE544, PHE450, SER447, ARG370, ALA453, VAL243 No match.
PLA2 LEU64, THR61, LYS62, PHE63, PHE63 No match.
α-pinene COX-1 TYR385, LEU390, HIS388, MET391, ALA199, ALA202, TRP387 TYR385, HIS388, TRP387
COX-2 ALA199, HIS388, TYR385, TRP387, LEU390, MET391, ALA202 TYR385, TRP387
5-LOX VAL645, LEU641, PRO664, LEU617, MET619, ARG638 No match.
PLA2 PHE63, THR61, PHE63, LYS62, LEU64 No match.
β-pinene COX-1 HIS388, LEU390, TYR385, TRP387, ALA202, MET391 TYR385, HIS388, TRP387
COX-2 HIS388, LEU390, TYR385, TRP387, ALA202, MET391 TYR385, TRP387
5-LOX LEU641, LEU617, VAL645, PRO664, MET619, ARG638 No match.
PLA2 PHE98, PHE5, ALA94, HIS47, CYS28, CYS44 PHE5, CYS44, HIS47
AA COX-1 CYS47, CYS36, PRO156, PRO153, TYR130, HIS43, ILE46, LYS468, CYS41, LEU152, ARG469, PRO40 No match.
COX-2 LEU152, TYR39, CYS47, CYS36, PRO156, PRO153, TYR130, ILE46, HIS43, CYS41 No match.
5-LOX MET231, LEU230, LYS319, LEU237, GLN656, TYR234, LEU657 No match.
PLA2 HIS47, CYS28, HIS27, ASP48, GLY29, TYR51, LEU2, ALA17, PHE5, ILE9, TYR21, PHE98, CYS44 PHE5, ILE9, TYR21, GLY29, CYS44, HIS47, TYR51
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated